Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis
AbstractAttention-deficit/hyperactivity disorder (ADHD) is a major public health issue. Pharmacological treatments play an important role in the multimodal treatment of ADHD. Currently, there is a lack of up-to-date and comprehensive evidence on how available ADHD drugs compare and rank in terms of efficacy and tolerability, in children or adolescents as well as in adults. We will conduct a network meta-analysis (NMA), integrating direct and indirect comparisons from randomised controlled trials (RCTs), to rank pharmacological treatments for ADHD according to their efficacy and tolerability profiles.
| BMJ open Cortese 2017.pdf
Tipologia: versione editoriale
Dimensione 963.41 kB
Formato Adobe PDF
|963.41 kB||Adobe PDF||Visualizza/Apri|
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.